NAMSA
Contract Research Organization for Medical Devices and IVDs
Home
/ test course 2
test course 2
do not purchase this test course
SKU:
WPMUDEV_Field_Text
Description
Description
nope
Search for:
Pages
Client Portals
Home
Website Accessibility Statement
Expertise
Subject Matter Experts
Therapeutic Expertise
Cardiovascular
Heart Valve Device Testing
Pacemaker Device Testing
Dental
Other Therapeutic Areas
General Surgery
Wound Care
Neurology
IVD & Companion Diagnostics
Ophthalmology
Orthopedics
Peripheral Vascular
Anesthesia / Respiratory
Diabetics
Diagnostic Imaging
Ear / Nose / Throat
Gastroenterology
Oncology
OBSTETRICS & GYNECOLOGY (OB/GYN)
Regenerative Medicine
Services
Preclinical Research
Medical Writing Solutions
Product Development Strategy
Meet the Experts: Product Development Strategy Team
Medical Device Regulatory & Quality
Biological Safety
Medical Device Testing
In Vitro and Ex Vivo Tissue Models
Biofilm Testing for Medical Devices
Biocompatibility Testing
Method Development & Validation
Medical Device Microbiology Testing
NAMSA APEX Program™
Medical Device Reimbursement
MedTech Market Research Consulting
Sterilization Validation
Clinical Research
IVD
Product Development Strategy
APEX Program
Medical Device Regulatory & Quality
Sign Up Thank You
ÅKRN
SUAZIO
SUAZIO
Sign Up
Account
Perfectus Biomed Group
Cart
APS
European Union’s General Data Protection Regulation Frequently Asked Questions – Vendors
Clinlogix
Medanex
European Union’s General Data Protection Regulation Frequently Asked Questions – Clients
Checkout
Opportunities to Accelerate Clinical Research Through Outpatient Site Networks
The Critical Role of Toxicologists in Chemical Characterization
The APEX Program Advantage
Syntactx
The Importance of Selecting the Right Partner
Strategies for Selecting the Proper Investigational Sites for Pivotal Studies
NAMSA’s Clinical Research Capabilities
The Value of Market Insights
Trends in MedTech Outsourcing
Key Considerations for Chemical Characterization Programs
Understanding Today’s MedTech Landscape for Start-Ups: Part 1
Flexible Strategies for Outsourcing Clinical Research: Augmented and Full Sourcing Models
Best Practices for Conducting Medical Device Antiviral and Microbial Testing
Considerations for Selecting the Best-Fit MedTech Regulatory Partner
Resources
Monkeypox IVD Resources
Checklists and Sample Submission Forms
EU MDR & IVDR Planning Resources
MedTech Podcast and Video Series
MedTech Matters Video Series
The MDR and IVDR Transitional Provision Extension: What EU Sponsors Must Understand for Compliance
RA QA Café Podcast
Updates on the IVDR
Risk Management, Clinical Evidence and Post-Market Reporting
Effective Communication with Notified Bodies
RAQA Café Live! – RAPS EU Convergence and Effective MDR-Compliant Periodic Safety Update Reports
Talking Risk with Dr. Naveen Agarwal-Part 2
Talking Risk with Dr. Naveen Agarwal-Part 1
Compliance Pitfalls of In Vivo Studies—How to Learn from the Mistakes of Others
The EU IVDR: What Do You Need To Know?
Clinical Investigations: Collecting Proof That Your Device is Safe and Effective
IVD Special – Software in a Medical Device (SiMD) vs. Software as a Medical Device (SaMD): Understanding Regulatory Differences and Expectations
Software in a Medical Device (SIMD) vs. Software as a Medical Device (SaMD): Understanding Regulatory Differences and Expectations
Refuse to Accept Policy and the Future of FDA Submissions
Choosing the Right Consultant
BiocompCHATibility Podcast
Chemistry with the MFDS
New FDA Biocompatibility Guidance – Let’s Discuss
NAMSA Awarded ASCA Accreditation
Welcome to the RA QA Café
What Exactly is my Test Article?
Biocompchatibility – Welcome
CSI: Cracking the Case
Extractions: The How and Why
FDA Thoughts On Chemical Characterization
Don’t Forget Packaging!
Welcome to NAMSA: Lisa Olson
Editor Chat: Biocompatibility and Performance of Medical Devices
NAMSA Training Series: Live from Philadelphia
NAMSA Training Series: Live from Frankfurt
Discussion with Chemical Characterization “A-Lister” Ted Heise on the New ISO 10993-18
Reusable Devices and the Challenges with Biocompatibility
Answering Your Questions on ISO 10993-18:2020
The QB1 of GLP
Biological Equivalency: When is “same” the same?
The Biological Evaluation Plan: A Manufacturer’s Perspective with Guest Dave Parente of Ecolab
Biocomp and Beer
Covid 19: Biocompatibility of Ventilators and Respiratory Devices
Biocompatibility FAQ
Listener MailBag – We Answer Your Questions
FDA and ISO 10993-18:2020
Why Biocompatibility Cares about Preclinical: NAMSA and APS Discuss
When to Go with In Vitro: Your Irritation Questions Answered
Oh No, Another Failed Cyto!
Is your Biocompatibility Program Knocking your Submission Off Track?
The Facts About In Vitro Irritation
Intact Skin Contact Devices: To Test or Not to Test
What in the World is the FDA’s Lab Accreditation Program – ASCA?
ISO 10993-4: The Second Most Misunderstood Section of 10993
Finding the Qualified Biocompatibility Unicorn
Biocompatibility and the Pre-Submission Meeting – The Devil is in the Details
A Start-up Biocompatibility Story – Prescient Surgical
COVID-19 IVD Resources
Blog
Resource Library
NAMSA Medical Device Test Navigators
Medical Device Test Navigator
Biocompatibility Strategy Navigator
E-Learning
Careers
NAMSA’s Client Standard Terms and Conditions
EU-U.S., UK Extension & Swiss-U.S. Data Privacy Framework
Website Privacy Statement
Website Terms of Use
APEX Program Consultation
NAMSA Purchasing Terms and Conditions
Contact
About
Accreditations & Certifications
NAMSA Leadership
Locations
Our History
Client Testimonials
Our Values
FAQ
Events
Certifications and Accreditations
Site Map
Archives
May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
August 2019
July 2019
June 2019
May 2019
March 2019
February 2019
January 2019
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
February 2018
January 2018
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
November 2016
April 2016
Categories
Asian Market
(14)
Clinical
(21)
Clinical & Consulting
(25)
European Market
(63)
FDA
(51)
Histology
(1)
Industry Reposts
(5)
IVD
(24)
Medical Device Testing
(19)
Medical Writing
(4)
Microbiology
(4)
NAMSA Press Release
(23)
Preclinical
(4)
Press Release
(5)
Quality
(9)
Regulatory
(130)
Reimbursement
(4)
Toxicology
(3)
Uncategorized
(6)
